The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20140184: Orange Capital Offshore I, Ltd.; PHH Corporation
20140221: Carl C. Icahn; Hologic, Inc.
Southeast Trust, LLC, formerly known as The Debt School, LLC and d/b/a Financial Freedom Credit Counseling, et al.
American Mortgage Consulting Group, LLC, also d/b/a American Mortgage Group and American Mortgage Consulting, et al.
20140056: Advance Auto Parts, Inc.; General Parts International, Inc.
20140202: International Business Machines Corporation; Fiberlink Communications Corp.
20140205: Zebra Technology Corporation; Topspin Partners LBO, L.P.
20140235: TCV VII, L.P.; Spotify Technology S.A.
20140265: Moelis Capital Partners Opportunity Fund I, LP; Fair Oaks Anesthesia Associates, P.C.
20140282: William B. Reily, III; New England Tea & Coffee Co., Inc.
20140285: Genstar Capital Partners V, L.P.; Charlesbank Equity Fund VI, Limited Partnership
Actavis, Inc. and Warner Chilcott PLC, In the Matter of
Under a settlement, the FTC required Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.The settlement protects competition in the markets for 21 current and future generic drugs, used to treat a wide range of conditions ranging from hypertension and diabetes to anxiety and attention deficit hyperactivity disorder (ADHD).